Recruiting
Colon cancer
RecruitingA study to evaluate the safety and effectiveness of darizmetinib hydrochloride in patients who have had liver surgery due to colon cancer metastases
Investigational
A study to evaluate the safety and effectiveness of darizmetinib hydrochloride in patients who have had liver surgery due to colon cancer metastases
Investigational
- Disease:Colon cancer
- Substances:Darizmetinib hydrochloride
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Darizmetinib hydrochloride


